8-Fluoro Erythromycin (CAS 82664-20-8)

8-Fluoro Erythromycin, a broad-spectrum antibiotic derived from Streptomyces bacteria, serves as useful in combating bacterial infections. As a semi-synthetic derivative of thiamphenicol, a naturally occurring antibiotic, it has undergone extensive laboratory studies to assess its ability to impede bacterial growth. Remarkably, 8-Fluoro Erythromycin has demonstrated efficacy against a wide range of bacteria, encompassing both gram-positive and gram-negative strains. Its effectiveness spans various bacterial infections, including those affecting the urinary tract, respiratory system, skin, and gastrointestinal tract. Moreover, research has delved into its potential to mitigate the emergence of antibiotic-resistant bacterial strains. The mechanism of action of 8-Fluoro Erythromycin revolves around the inhibition of bacterial protein synthesis. By binding to the 50S ribosomal subunit within bacterial cells, it hinders the formation of the initiation complex essential for protein synthesis initiation. Consequently, bacteria are unable to produce the proteins required for their growth and survival, impeding their proliferation and curbing the infection.